Harald Rinde Md, Mba Email & Phone Number

Basel Area, Switzerland

Harald works with BioBridge Strategies, a consulting firm that develops strategic and operational solutions for young and mature pharmaceutical, biotech, diagnostic, health informatics and health services companies focusing on the “new biology”. I have worked with about 80 different clients. Many of these companies have been clients for several years with many separate projects. Clients also include non-profit organizations, including World Health Organization and Bill & Melinda Gates Foundation. A key focus of these projects was aspects of bridging public organizations with industry for long-term sustainable collaborations.

Halteres help transform medical discovery and innovation into viable solutions that can impact the world. Harald is a Health Economist and Principal at Halteres Associates helping to establish the “value” in high value diagnostics through “Impact Modeling”.

Binningen, Switzerland

Acting VP Global Marketing & Business Development for a Boston based Biotech company. CEO (interim), Freiburg, Germany. Established a start-up oncology company with a novel patented tumor targeting pro-drug technology with a lead compound completing Phase I clinical trial. Associate Partner health4u AG, Allschwil, Switzerland: Managed the European clinical development and developing the European Marketing Strategy for an in-vitro Alzheimer’s Disease diagnostic test. Developed patient centered services and solutions for pharmaceutical companies. Senior Consultant Pharma & Healthcare for a start-up Health Information Technology company, Basel, Switzerland: Helped build the eClinical Solutions business. Developed a range of patient handheld eDiaries and mobile electronic Disease Management tools.Consulted for Biotech, Pharmaceutical & Health Services companies. Clients included: Pfizer, Novartis, Ratiopharm, Chiron Therapeutics, Swiss Medical Call Centre, PriceWaterhouseCoopers, Hesperion.

Basel Area, Switzerland

Disease Management at Ciba-Geigy focused on Market Access and Integrated Healthcare. Harald established and managed the activities throughout Ciba’s global organization. Developed and launched a range of programs in the USA, Canada and Europe resulting in measurable outcomes improvements. Responsible for marketing activities using new technologies and novel marketing tools, including Internet & Health Informatics.Managed the special Project Group “Global Marketing Portfolio Management Processes” and coordinated the task forces “Marketing Processes” and “Global Pharmaceuticals Portfolio” during the Novartis Merger process.

Basel Area, Switzerland

Products included developing and commercializing Novartis’ $6 billion Diovan/valsartan (for treatment of hypertension, heart failure, and post-myocardial infarction) and a broad range of products in various stages of their lifecycle. These ranged from products in early development (e.g., Revasc/hirudin, a thrombin inhibitor) to Nicotinell/Habitrol (nicotine patch), which included the successful transition to over-the-counter drug, and late stage products like Cibacen/Lotensin (ACE inhibitor).

Basel Area, Switzerland

Helped the establishment of the Novartis oncology portfolio, including the development and global strategy for $1.3 billion Femara/letrozole (for treatment of breast cancer) and $700 million Aredia (bisphosphonate). Planned and managed the European launch of Lentaron (breast cancer). Initiated, developed and launched a “Cancer Pain Management” program.

London, United Kingdom

Marketing research and strategic consulting for private hospitals

Torsken, Norway

Sole GP covering an area previously covered by three physicians. On-call 24/7

Bodo, Norway

General Surgery, Internal Medicine, Plastic Surgery.

Master Of Business Administration (Mba), Health/Health Care Administration/Management, Marketing

Md, Medicine